Ossur Outlook - Q3 2008
Highlights:
At a Board of Directors meeting 10 October, it was decided to publish immediately outlook for Q3. This is done in light of highly unusual situation at the financial markets and in order to facilitate and enable primary insiders to trade their shares. The Financial Statements are in the process of being finalized. This outlook is based on actual performance for July and August and estimates for September. One-time other income includes USD 2 million due to milestone payment from the advanced wound care product line which was divested earlier this year.
For further details, see the press release in the attachment.